New data to be presented at the American Society of Breast Surgeons Annual Meeting shows fluid and body composition assessments improve early detection accuracy ImpediMed,
Treatment well-tolerated and patient remains on study with stable disease elsewhere BriaCell Therapeutics Corp. , a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care,
Despite strong performance from AI, fewer recalls from AI-flagged cases point to challenges in human-AI collaboration Lunit, a leading provider of AI-powered solutions for cancer
Smart Opinion, a Tokyo-based company specializing in AI-powered breast cancer screening tools, has been selected to participate in Phase 2 of the HealthTech Gateway “AI
Fuel up with free Health Tech Insights
